Fundraising Fox
Vivus
2 known investors
Find your way into Vivus
Each arrow is one introduction. Sign up to fill in the first one.
113 people can intro you to Santosh
Ask Carlos Paya to introduce you to Santosh T. Varghese
You →Carlos · together at Elan Pharmaceuticals →Santosh
91 people can intro you to John
Ask Jamie Chen to introduce you to John Amos
You →Jamie · together at MD Anderson Cancer Center →John
Sign up to find every way you can get introduced to Vivus
- Your email: who you already know at Vivus, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vivus team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases. The company advances innovative treatments through clinical development and commercialization expertise.
Founders & leadership
JA
John AmosChief Executive Officer
ST
Santosh T. VarghesePresident VIVUS Global Pharmaceutical Development & Chief Medical OfficerSantosh T. Varghese has over 25 years of pharmaceutical industry experience spanning clinical development, medical affairs, and regulatory strategy across cardiovascular, endocrinology, immunotherapy, CNS, and multiple other therapeutic areas. He holds medical training in general medicine and has led cross-functional teams in clinical development, medical affairs, pharmacovigilance, and regulatory organizations.
Investors · 2
Frequently asked questions
- What does Vivus do?
- VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases. The company advances innovative treatments through clinical development and commercialization expertise.
- Who are Vivus's investors?
- Vivus's investors include Aisling Capital, Frazier Life Sciences.